Treating Drug Resistant Malaria
- Business: Drug Discovery
- CEO: Philip S. Low
World Health Organization estimates that in 2015 there were 214 million new cases of malaria resulting in 438,000 deaths. The majority of cases (65%) occur in children under 15 years old. Resistance is now common against most classes of antimalarial drugs. Dr. Philip Low is developing a new class of therapy that prevents escape of malaria parasite from the red blood cell. With support from generous donations of Hurvis Family and Purdue alumni clinical trials have been initiated.
Local Partners: Mbale Regional Referral Hospital, Mbale Uganda